What is the appropriate workup and differential diagnosis for a 56-year-old woman with a one-month history of intermittent flushing and dizziness?

Workup and Differential Diagnosis for 56-Year-Old Woman with Intermittent Flushing and Dizziness

Immediate Priority: Exclude Life-Threatening Neuroendocrine Causes

The first-line workup must exclude carcinoid syndrome, pheochromocytoma, and systemic mastocytosis before attributing symptoms to benign causes like menopause or benign paroxysmal positional vertigo. 1

---

Critical Differential Diagnoses

Life-Threatening Causes (Must Exclude First)

• Carcinoid syndrome – Episodic dry flushing (without sweating) lasting minutes to hours, often with diarrhea, abdominal pain, and right-sided valvular heart disease 1
• Pheochromocytoma – Episodic wet flushing (with diaphoresis), paroxysmal hypertension, severe headache, palpitations, and anxiety 1
• Systemic mastocytosis – Intermittent flushing with urticaria, pruritus, abdominal pain, diarrhea, and urticaria-pigmentosa skin lesions 1
• Posterior circulation stroke – In patients >50 years with vascular risk factors, 11-25% with acute vestibular syndrome have stroke even with normal neurologic exam 2

Common Benign Causes

• Menopausal vasomotor symptoms – 50-75% of women aged 45-56 experience hot flashes and night sweats lasting >7 years 3
• Benign paroxysmal positional vertigo (BPPV) – Most common cause of peripheral vertigo (42% of cases), triggered by head position changes, episodes lasting <1 minute 2, 4
• Vestibular migraine – Accounts for 14% of vertigo cases but markedly under-recognized, episodes lasting minutes to hours with photophobia/phonophobia 2
• Medication side effects – Leading reversible cause of chronic dizziness, particularly antihypertensives, sedatives, anticonvulsants 2

---

Essential History Elements

Flushing Characteristics

• Wet vs. dry flushing – Wet flushing (with sweating) suggests pheochromocytoma or panic disorder; dry flushing suggests carcinoid or mastocytosis 1
• Duration – Minutes to hours suggests carcinoid; brief episodes suggest menopause 1, 3
• Triggers – Food/alcohol (carcinoid), head position changes (BPPV), stress (pheochromocytoma) 1

Dizziness Characteristics

• Duration – Seconds (<1 minute) suggests BPPV; minutes to hours suggests vestibular migraine or Ménière's; days to weeks suggests vestibular neuritis or stroke 2
• Triggers – Specific head position changes (BPPV) vs. spontaneous (vestibular migraine, Ménière's) 2
• Associated symptoms – Hearing loss/tinnitus/aural fullness (Ménière's); headache/photophobia/phonophobia (vestibular migraine); focal neurologic deficits (stroke) 2

Red-Flag Symptoms Requiring Urgent Imaging

• Severe hypertension with flushing 1
• Focal neurologic deficits (dysarthria, limb weakness, diplopia) 2, 1
• Sudden unilateral hearing loss 2, 1
• Inability to stand or walk 2, 1
• New severe headache with dizziness 2, 1
• Diarrhea and abdominal pain with flushing (carcinoid) 1

---

Physical Examination

Cardiovascular

• Cardiac auscultation – Tricuspid regurgitation murmur indicates carcinoid heart disease (present in 59% of carcinoid patients) 1
• Blood pressure – Check for paroxysmal hypertension (pheochromocytoma) 1

Dermatologic

• Skin examination – Look for urticaria-pigmentosa (mastocytosis) or telangiectasias (carcinoid) 1

Vestibular Testing

• Dix-Hallpike maneuver (bilateral) – Gold standard for BPPV; positive test shows torsional upbeating nystagmus with 5-20 second latency, resolving within 60 seconds 2, 1
• Supine roll test – If Dix-Hallpike negative, perform to detect lateral canal BPPV (10-15% of BPPV cases) 2
• HINTS examination – If trained examiner available and acute vestibular syndrome present; 100% sensitive for stroke when performed by experts 2

Neurologic

• Complete neurologic exam – Assess for dysarthria, dysmetria, dysphagia, sensory/motor deficits, diplopia, Horner's syndrome 2, 4
• Nystagmus characteristics – Pure vertical nystagmus without torsional component, direction-changing nystagmus, or baseline nystagmus without provocation all suggest central pathology 2, 4, 1

---

First-Tier Laboratory Evaluation

Test	Purpose	Interpretation
24-hour urinary 5-HIAA	Exclude carcinoid syndrome	>300 µmol/24h associated with carcinoid heart disease [1]
Plasma-free metanephrines or 24-hour urinary metanephrines/VMA	Exclude pheochromocytoma	Elevated levels diagnostic [1]
Serum tryptase (1-2h after symptom onset)	Detect mastocytosis/anaphylaxis	Remains elevated up to 6 hours [1]
CBC	Screen for polycythemia	Can cause flushing [1]
Fasting glucose	Exclude hyperglycemia-related symptoms	Elevated supports metabolic cause [1]
Basic metabolic panel	Assess electrolytes/renal function	Guides further management [1]
FSH level	Confirm menopausal status	Elevated confirms menopause [3]

---

Imaging Recommendations

When Imaging Is NOT Required

• Typical BPPV with positive Dix-Hallpike test and no red-flag features 2, 1
• Acute persistent vertigo with normal neurologic exam and peripheral HINTS pattern by trained examiner in low vascular risk patient 2
• Nonspecific dizziness without vertigo, ataxia, or neurologic deficits 2

When MRI Brain Without Contrast Is MANDATORY

• Age >50 with vascular risk factors (hypertension, diabetes, atrial fibrillation, prior stroke) even with normal exam 2, 1
• Abnormal neurologic examination 2, 1
• HINTS examination suggesting central cause 2, 1
• Any red-flag features: focal deficits, sudden hearing loss, inability to walk, downbeating/purely vertical nystagmus, direction-changing nystagmus, new severe headache, progressive symptoms 2, 1

MRI has 4% diagnostic yield vs. <1% for CT; CT misses most posterior circulation infarcts (sensitivity 10-20%) 2, 1

Additional Imaging If Neuroendocrine Tumor Suspected

• CT abdomen/pelvis with contrast – Locate primary carcinoid tumor and metastases 1
• Octreotide scan – Localizes confirmed carcinoid tumors 1
• Echocardiogram – Evaluate carcinoid heart disease 1

---

Second-Tier Testing (If First-Tier Negative)

• Serum chromogranin A – Elevated in neuroendocrine tumors, less specific than 5-HIAA 1
• Bone marrow biopsy – Diagnostic for systemic mastocytosis when tryptase elevated and skin lesions present 1
• Comprehensive audiometry – If hearing loss, tinnitus, or aural fullness present to distinguish Ménière's from vestibular migraine 2

---

Treatment Algorithm Based on Diagnosis

If BPPV Confirmed (Positive Dix-Hallpike)

• Perform Epley maneuver immediately – 80% success after 1-3 treatments, 90-98% with repeat maneuvers 2, 1
• Do NOT prescribe vestibular suppressants – They prevent central compensation 2
• Reassess within 1 month – Document resolution or persistence 2

If Menopausal Vasomotor Symptoms (After Excluding Neuroendocrine Causes)

• First-line: Systemic estrogen – Reduces vasomotor symptoms by 75%; oral and transdermal have similar efficacy 3
• If hormone therapy contraindicated – Paroxetine (only FDA-approved SSRI), venlafaxine, desvenlafaxine, citalopram, escitalopram, or gabapentin reduce symptoms by 40-65% 3, 5

If Vestibular Migraine

• Migraine prophylaxis and lifestyle modifications – Essential treatment 2
• Avoid triggers – Motion, light sensitivities 2

If Carcinoid/Pheochromocytoma/Mastocytosis Confirmed

• Immediate referral to endocrinology/oncology for definitive management 1

---

Critical Pitfalls to Avoid

• Assuming normal neurologic exam excludes stroke – 75-80% of posterior circulation strokes lack focal deficits 2, 1
• Relying on CT instead of MRI for suspected stroke – CT misses most posterior circulation infarcts 2, 1
• Failing to perform Dix-Hallpike maneuver – Gold standard for BPPV diagnosis 2, 1
• Attributing symptoms to menopause without excluding neuroendocrine tumors – Carcinoid and pheochromocytoma are life-threatening 1
• Overlooking medication side effects – Leading reversible cause of chronic dizziness 2
• Missing vestibular migraine – Accounts for 14% of vertigo cases but markedly under-recognized 2